• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and Korea

tetano

Editor, Senior Moderator
Viruses


. 2023 Feb 20;15(2):582.
doi: 10.3390/v15020582.
Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and Korea


Yun Young Go[SUP] 1 [/SUP], Maura Carrai[SUP] 2 [/SUP], Yan Ru Choi[SUP] 2 [/SUP], Christopher J Brackman[SUP] 3 [/SUP], Karina W S Tam[SUP] 3 [/SUP], Pierra Y T Law[SUP] 3 [/SUP], Fiona Woodhouse[SUP] 4 [/SUP], Jane Gray[SUP] 4 [/SUP], Ji Hun Kim[SUP] 5 [/SUP], Joohyung Park[SUP] 6 [/SUP], Chae Won Jeon[SUP] 7 [/SUP], Hyomi Jang[SUP] 7 [/SUP], Ioannis Magouras[SUP] 1 [/SUP], Nicola Decaro[SUP] 8 [/SUP], Samuel M S Cheng[SUP] 9 [/SUP], Malik Peiris[SUP] 9 [/SUP], Julia A Beatty[SUP] 2 [/SUP], Vanessa R Barrs[SUP] 2 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide since its emergence in 2019. Knowing the potential capacity of the virus to adapt to other species, the serological surveillance of SARS-CoV-2 infection in susceptible animals is important. Hong Kong and Seoul are two of Asia's most densely populated urban cities, where companion animals often live in close contact with humans. Sera collected from 1040 cats and 855 dogs during the early phase of the pandemic in Hong Kong and Seoul were tested for SARS-CoV-2 antibodies using an ELISA that detects antibodies against the receptor binding domain of the viral spike protein. Positive sera were also tested for virus neutralizing antibodies using a surrogate virus neutralization (sVNT) and plaque reduction neutralization test (PRNT). Among feline sera, 4.51% and 2.54% of the samples from Korea and Hong Kong, respectively, tested ELISA positive. However, only 1.64% of the samples from Korea and 0.18% from Hong Kong tested positive by sVNT, while only 0.41% of samples from Korea tested positive by PRNT. Among canine samples, 4.94% and 6.46% from Korea and Hong Kong, respectively, tested positive by ELISA, while only 0.29% of sera from Korea were positive on sVNT and no canine sera tested positive by PRNT. These results confirm a low seroprevalence of SARS-CoV-2 exposure in companion animals in Korea and Hong Kong. The discordance between the RBD-ELISA and neutralization tests may indicate possible ELISA cross-reactivity with other coronaviruses, especially in canine sera.

Keywords: COVID-19; SARS-CoV-2; canine; feline; seroprevalence; zoonosis.
 
Back
Top Bottom